Azitra, Inc. (AZTR): Insider Trading, Congress Trades & Research | Tormere

AZTR

$0.82-7.71%visit website

Azitra, Inc.

Market Cap

$13M

Live price × Finnhub shares (2026-09-18)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

-0.83

40mo monthly vs SPY

P/E (TTM)

—

Price / TTM diluted EPS

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

—

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	0.00	0.00
Research & development	1,180	1,004	1,561	1,352	5,096
Total operating expenses	2,768	2,227	3,934	3,419	12,348
Operating income	(2,768)	(2,227)	(3,934)	(3,419)	(12,348)
Interest expense	0.4	5.5	3.4	1.4	10.6
Pretax income	(2,765)	(2,225)	(3,927)	(3,348)	(12,265)
Income tax	0.00	8.32	0.00	0.00	8.32
Net income	(2,765)	(2,234)	(3,927)	(3,348)	(12,273)
EPS (basic) ($)	(0.67)		(0.25)	(0.17)	—
EPS (diluted) ($)	(0.67)		(0.25)	(0.17)	—
Weighted avg. shares (basic)	4,118		15,518	19,301
Weighted avg. shares (diluted)	4,118		15,518	19,301

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 12, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 13 more quarters, back to Jun 2022, with Tormere Pro.

Signals

Insider Velocity

no recent activity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

Salva Francisco D. · 2026-06-24

No Form 4 transactions on record.

Recent News

Azitra (AZTR) Analyst Ratings, Stock Forecast and Price Target

Moomoo · 2026-11-03

Why Is AZTR Stock Rising Today?

Stocktwits · 2026-11-02

AZTR: Update on Rash, Fine Lines & Elasticity

Yahoo · 2026-11-02

Azitra, Inc. Expands Eligibility for ATR-04 Phase 1/2 Clinical Trial to Include Patients with Rashes due to KRAS and MEK Inhibitors

Yahoo · 2026-10-29

Azitra Expands Eligibility For Ongoing Phase 1/2 Clinical Trial Of ATR04-484 To Include Individuals With Rash Associated With KRAS And MEK Inhibitors

Benzinga · 2026-10-29

Top Premarket Decliners

Yahoo · 2026-10-27

Why Celestica Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

Benzinga · 2026-10-27

Azitra, Inc. Announces Revitalizing Results from Ex Vivo Study of ATR-COSF Demonstrating Ability to Reduce Fine Lines and Improve Elasticity in Human Skin

Yahoo · 2026-10-26

One dose cut the appearance of wrinkles by about 50% in human skin samples after 48 hours

Stock Titan · 2026-10-26

Azitra Suspends ATM Offering Program For The Foreseeable Future; From September 28, 2026 - October 26, 2026, The Company Sold An Aggregate Of 1,000 Shares Of Common Stock Under The ATM Program For Aggregate Gross Proceeds Of ~$126

Benzinga · 2026-10-26

Azitra To Present Progress For Its Cosmetic ATR-COSF Program Targeting Fine Lines And Wrinkles At Bio-europe, November 10; First-In-Human Study With ATR-COSF Initial Results Anticipated By End Of 2026

Benzinga · 2026-10-26

Azitra, Inc. Announces Reverse Stock Split

Yahoo · 2026-10-16

Top stock movements in today's session.

ChartMill · 2026-10-13

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga · 2026-10-13

12 Health Care Stocks Moving In Tuesday's After-Market Session

Benzinga · 2026-10-06

Informational purposes only, not investment advice.

Corporate Events (8-K)

2 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 29, 2026 accepted 8:35 AM ET	8.01Other events	Document SEC ↗
Oct 26, 2026 accepted 8:50 AM ET	8.01Other events	Document SEC ↗